Evaluation of fulminant hepatic failure by scintigraphy with technetium- 99m-GSA

Journal of Nuclear Medicine

Volumn 38, Issue 1, 1997, Pages 79-82

  Shiomi, Susumu ^a   Kuroki, Tetsuo ^a   Kuriyama, Maki ^a   Takeda, Tadashi ^a   Nishiguchi, Shuhei ^a   Nakajima, Shinya ^a   Tanaka, Takashi ^a   Ochi, Hironobu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

asialoglycoprotein receptor; fulminant hepatic failure; technetium 99m GSA

Indexed keywords

ASIALOGLYCOPROTEIN; ASIALOGLYCOPROTEIN RECEPTOR; PENTETATE TECHNETIUM TC 99M; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC IMAGING; FEMALE; HEPATITIS; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FUNCTION; LIVER SCINTISCANNING; MALE; PRIORITY JOURNAL; SCINTILLATION CAMERA;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS; HUMANS; LIVER; MALE; MIDDLE AGED; PROGNOSIS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE;

EID: 0031013163     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Trey C, Davidson C. The management of fulminant hepatic failure. In: Popper H, Schaffner F, eds. Progress in liver diseuse. Philadelphia: Grune and Stratton; 1970;282-298.
2. O'Grady JG, Gimson AES, O'Brien CJ, Pucknell A, Hughes RD, Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 1988;94:1186-1192.
3. Christensen E, Bremmelgaard A, Bahnsen M, Andreasen PB, Tygstrup N. Prediction of fatality in fulminant hepatic failure. Scand J Gastroenterol 1984;19:90-96.
4. Harrison PM, O'Grady JG, Keays RT, Alexander GJM, Wiliams R. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. Br Med J 1990;301:964-966.
5. Waxman AD. Scintigraphic evaluation of diffuse hepatic disease. Semin Nucl Med 1982;12:75-88.
6. Shiomi S, Ikeoka N, Minowa T, et al. Diagnostic value of liver scintigraphy in fulminant hepatitis and severe acute hepatitis. Acta Hepatol Jpn 1985;26:592-597.
7. Fleischer MR, Sharpstone P, Osborn SB, Williams R. Liver scintiscanning in acute hepatic necrosis. Br J Radiol 1971;44:401-402.
8. Kumahara T, Muto Y, Moriwaki H, Yoshida T, Tomita E. Determination of the integrated CT number of the whole liver in patients with severe hepatitis as an indicator of the functional reserve of the liver. Gastroenterol Jpn 1989;24:290-297.
9. Kurtz AB, Rubin CS, Cooper HS, et al. Ultrasound findings in hepatitis. Radiology 1980;136:717-723.
10. Stadalnik RC, Vera DR, Woodle ES, et al. Technetium-99m-NGA functional hepatic imaging: preliminary clinical experience. J Nucl Med 1985;26:1233-1242.
11. Kudo M, Todo A, Ikekubo K, Hino M. Receptor index via hepatic asialoglycoprotein receptor imaging: correlation with chronic hepatocellular damage. Am J Gastroenterol 1992;87:865-870.
12. Takahashi Y, Shimizu M, Study Group of Fulminant Hepatitis. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicenter study. J Gastroenterol Hepatol 1991;6:159-164.
13. Stern HS, McAfee JG, Subramanian G. Preparation, distribution and utilization of technetium-99m-sulfur colloid. J Nucl Med 1966;7:665-675.
14. Antar MA, Sziklas JJ, Spencer RP. Liver imaging during reticuloendothelial failure. Clin Nucl Med 1977;2:293-295.
15. 99mTc-labeled hepatobiliary agent. Clin Nucl Med 1981;6:289-294.
16. Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 1986;6:648-651.
17. O'Grady JG, Alexander GJM, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-445.
18. Donaldson BW, Gopinath R, Wanless IR, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology 1993;18:1370-1374.